Patent · US Active

GABAA positive allosteric modulator compounds for treatment of itch and/or dermatitis

US11571421B2 · kind B2 · utility

0Cited by
2References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2020
Grant dateFeb 7, 2023
Priority date—
Expiry dateNov 17, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/1075
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are GABAA positive allosteric modulators for the treatment of pruritic conditions and dermatitis. Also disclosed herein are formulations comprising the GABAA positive allosteric modulators.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.